ATE180679T1 - Neue verbesserungen hinsichtlich der radiomarkierung von proteinen - Google Patents
Neue verbesserungen hinsichtlich der radiomarkierung von proteinenInfo
- Publication number
- ATE180679T1 ATE180679T1 AT92924841T AT92924841T ATE180679T1 AT E180679 T1 ATE180679 T1 AT E180679T1 AT 92924841 T AT92924841 T AT 92924841T AT 92924841 T AT92924841 T AT 92924841T AT E180679 T1 ATE180679 T1 AT E180679T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- nhr
- radiom
- labeling
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Developing Agents For Electrophotography (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919126650A GB9126650D0 (en) | 1991-12-16 | 1991-12-16 | Further improvements relating to the radiolabelling of proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE180679T1 true ATE180679T1 (de) | 1999-06-15 |
Family
ID=10706322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92924841T ATE180679T1 (de) | 1991-12-16 | 1992-12-15 | Neue verbesserungen hinsichtlich der radiomarkierung von proteinen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5762906A (de) |
| EP (1) | EP0618816B1 (de) |
| JP (1) | JPH07502502A (de) |
| AT (1) | ATE180679T1 (de) |
| CA (1) | CA2125975A1 (de) |
| DE (1) | DE69229356T2 (de) |
| GB (2) | GB9126650D0 (de) |
| WO (1) | WO1993011796A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL115177A0 (en) * | 1994-09-16 | 1995-12-31 | Immunomedics Inc | Phosphorus-32 labeling of antibodies for cancer therapy |
| US5728369A (en) * | 1994-10-05 | 1998-03-17 | Immunomedics, Inc. | Radioactive phosphorus labeling of proteins for targeted radiotherapy |
| WO1996023816A1 (en) * | 1995-02-01 | 1996-08-08 | British Technology Group Limited | Radiolabelled proteins |
| US6582417B1 (en) * | 1999-09-22 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | Methods and apparatuses for radiation treatment |
| US6605031B1 (en) | 1999-09-22 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Stepped centering balloon for optimal radiation delivery |
| US7994449B2 (en) | 2000-02-16 | 2011-08-09 | Advanced Cardiovascular Systems, Inc. | Square-wave laser bonding |
| US7163504B1 (en) | 2000-02-16 | 2007-01-16 | Advanced Cardiovascular Systems, Inc. | Multi-lumen fluted balloon radiation centering catheter |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1338860C (en) * | 1987-04-13 | 1997-01-21 | Peter Parker | Radiolabelling of proteins |
| GB2186579B (en) * | 1986-01-21 | 1990-07-25 | Brian Maurice John Foxwell | Improvements relating to the radio-labelling of proteins |
| GB2228262B (en) * | 1989-01-25 | 1992-10-07 | Nat Inst Immunology | Antigenic derivative of gnrh |
| GB8906708D0 (en) * | 1989-03-23 | 1989-05-10 | Foxwell Brian M J | Improvements relating to the radiolabelling of proteins |
| GB8916806D0 (en) * | 1989-07-22 | 1989-09-06 | Univ Wales Medicine | Modified proteins |
-
1991
- 1991-12-16 GB GB919126650A patent/GB9126650D0/en active Pending
-
1992
- 1992-12-15 US US08/244,855 patent/US5762906A/en not_active Expired - Fee Related
- 1992-12-15 DE DE69229356T patent/DE69229356T2/de not_active Expired - Fee Related
- 1992-12-15 GB GB9226144A patent/GB2262528B/en not_active Revoked
- 1992-12-15 CA CA002125975A patent/CA2125975A1/en not_active Abandoned
- 1992-12-15 JP JP5510739A patent/JPH07502502A/ja active Pending
- 1992-12-15 AT AT92924841T patent/ATE180679T1/de not_active IP Right Cessation
- 1992-12-15 EP EP92924841A patent/EP0618816B1/de not_active Expired - Lifetime
- 1992-12-15 WO PCT/GB1992/002322 patent/WO1993011796A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69229356D1 (de) | 1999-07-08 |
| GB2262528B (en) | 1995-08-16 |
| GB2262528A (en) | 1993-06-23 |
| GB9126650D0 (en) | 1992-02-12 |
| US5762906A (en) | 1998-06-09 |
| WO1993011796A1 (en) | 1993-06-24 |
| DE69229356T2 (de) | 1999-11-04 |
| GB9226144D0 (en) | 1993-02-10 |
| EP0618816B1 (de) | 1999-06-02 |
| CA2125975A1 (en) | 1993-06-24 |
| JPH07502502A (ja) | 1995-03-16 |
| EP0618816A1 (de) | 1994-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE161536T1 (de) | Neue mercaptoacetylamid-derivate zur verwendung als enkephalinase- und ace-hemmer | |
| PE86599A1 (es) | Inhibidores de la farnesil proteina transferasa | |
| ATE148130T1 (de) | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren | |
| ATE81779T1 (de) | Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren. | |
| ATE255125T1 (de) | Neue 7-beta-substituierte-4-aza-5-alpha-androstan-3- nen als inhibitoren von 5-alpha-reduktase | |
| CA2295219A1 (en) | Integrin binding peptide and use thereof | |
| KR950700323A (ko) | 엔케팔리나제 및 안지오텐신 전환 효소의 억제제로서 유용한 아미노아세틸머캅토아세틸아미드 유도체(Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE) | |
| DE69228749D1 (de) | Neuartige polypeptide und ihre verwendung | |
| DK0633763T3 (da) | Kosmetiske eller farmaceutiske sammensætninger indeholdende deacylerede glycerophospholipider til topisk brug | |
| ATE180679T1 (de) | Neue verbesserungen hinsichtlich der radiomarkierung von proteinen | |
| ATE63126T1 (de) | Tetra- und penta-peptide mit der sequenz lysylarginyl-aspartyl, und ihre verwendung als antithrombotika. | |
| DE69029377D1 (de) | Substituierungsanaloge von magaininpeptiden | |
| LV10108A (lv) | Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni | |
| ATE211719T1 (de) | Korrosionsinhibitoren enthaltender injektionszement | |
| ATE128450T1 (de) | Neue cyclopropylsqualenderivate und ihre verwendung als inhibitoren der cholesterinsynthese. | |
| ATE170631T1 (de) | Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase | |
| DE3769910D1 (de) | Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung. | |
| DE69102069D1 (de) | 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen. | |
| DE69829953D1 (de) | Kristallisation von proteinen | |
| ATE195147T1 (de) | Aminosäuren konjugaten | |
| ATE139995T1 (de) | Substituierte benzhydrylamine als anknüpfungsmoleküle bei der festphasenpeptidsynthese | |
| DE69733026D1 (de) | Cyclin e spezifische konstrukte und komplexe | |
| DE50015133D1 (de) | Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse | |
| DE69814133D1 (de) | Zusammensetzung um die löslichkeit von igf-i zu erhöhen | |
| DE68908958D1 (de) | Peptide. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |